The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Hims & Hers Health Inc (NYSE: HIMS) closed at $15.58 in the last session, down -0.83% from day before closing price of $15.71. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 6.19 million shares were traded. HIMS stock price reached its highest trading level at $15.7999 during the session, while it also had its lowest trading level at $15.3524.
Ratios:
We take a closer look at HIMS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.79. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On May 22, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $16 to $20.
Jefferies Downgraded its Buy to Hold on April 16, 2024, whereas the target price for the stock was revised from $17 to $15.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 16 ’24 when Becklund Irene bought 472 shares for $15.66 per share.
Boughton Soleil sold 2,334 shares of HIMS for $40,378 on Aug 06 ’24. The Chief Legal Officer now owns 164,475 shares after completing the transaction at $17.30 per share. On Aug 05 ’24, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 188,888 shares for $16.47 each. As a result, the insider received 3,110,912 and left with 33,502 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 3382106368 and an Enterprise Value of 3166287360. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 208.29, and their Forward P/E ratio for the next fiscal year is 28.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.17 while its Price-to-Book (P/B) ratio in mrq is 9.33. Its current Enterprise Value per Revenue stands at 2.967 whereas that against EBITDA is 118.194.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $25.74, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is -24.55%, while the 200-Day Moving Average is calculated to be 14.15%.
Shares Statistics:
According to the various share statistics, HIMS traded on average about 11.76M shares per day over the past 3-months and 12020440 shares per day over the past 10 days. A total of 205.10M shares are outstanding, with a floating share count of 163.98M. Insiders hold about 29.34% of the company’s shares, while institutions hold 57.73% stake in the company. Shares short for HIMS as of 1722384000 were 19258267 with a Short Ratio of 1.64, compared to 1719532800 on 17561078. Therefore, it implies a Short% of Shares Outstanding of 19258267 and a Short% of Float of 10.13.
